Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
Clinical trial NCT00509301 · COMPLETED
Trial details
- NCT number
- NCT00509301
- Sponsor
- Peregrine Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2010-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.